CY1108285T1 - Σφαιροειδη, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις - Google Patents
Σφαιροειδη, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσειςInfo
- Publication number
- CY1108285T1 CY1108285T1 CY20081100901T CY081100901T CY1108285T1 CY 1108285 T1 CY1108285 T1 CY 1108285T1 CY 20081100901 T CY20081100901 T CY 20081100901T CY 081100901 T CY081100901 T CY 081100901T CY 1108285 T1 CY1108285 T1 CY 1108285T1
- Authority
- CY
- Cyprus
- Prior art keywords
- sphereoid
- preparing
- pharmaceutical compositions
- spheroid
- directly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Η παρούσα ευρεσιτεχνία αναφέρεται σε απ'ευθείας συμπιέσιμο γαστρο-ανθεκτικό σφαιροειδές. Το σφαιροειδές της ευρεσιτεχνίας χαρακτηρίζεται εκ του ότι περιλαμβάνει: i) ένα πυρήνα περιέχοντα μία ή περισσότερες δραστικές ουσίες · ii) ένα εύκαμπτο, παραμορφούμενο φίλμ το οποίο χρησιμοποιείται για την απ' ευθείας επίχριση του προαναφερθέντος πυρήνος και το οποίο περιλαμβάνει ένα εντερικό πολυμερές και ένα μείγμα κορεσμένων και/ή ακόρεστων πολυγλυκοζυλιωμένων γλυκεριδίων, και των οποίων τα λιπαρά οξέα περιλαμβάνουν τουλάχιστον 8 άτομα άνθρακος • και μια εξωτερική στρώση διασκορπίσιμη στο νερό και περιέχουσα ένα τουλάχιστον παράγοντα αποσάθρωσης.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0212333A FR2845289B1 (fr) | 2002-10-04 | 2002-10-04 | Spheroides, procede de preparation et compositions pharmaceutiques. |
EP03775466A EP1549298B1 (fr) | 2002-10-04 | 2003-10-03 | Spheroides procede de preparation et compositions pharmaceutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108285T1 true CY1108285T1 (el) | 2014-02-12 |
Family
ID=32011398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100901T CY1108285T1 (el) | 2002-10-04 | 2008-08-25 | Σφαιροειδη, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις |
Country Status (17)
Country | Link |
---|---|
US (2) | US20060165794A1 (el) |
EP (1) | EP1549298B1 (el) |
JP (1) | JP4660192B2 (el) |
CN (1) | CN1713896B (el) |
AT (1) | ATE399001T1 (el) |
AU (1) | AU2003283492A1 (el) |
CA (1) | CA2501294C (el) |
CY (1) | CY1108285T1 (el) |
DE (1) | DE60321801D1 (el) |
DK (1) | DK1549298T3 (el) |
ES (1) | ES2307993T3 (el) |
FR (1) | FR2845289B1 (el) |
HK (1) | HK1077023A1 (el) |
MX (1) | MXPA05003588A (el) |
PT (1) | PT1549298E (el) |
SI (1) | SI1549298T1 (el) |
WO (1) | WO2004030657A1 (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1621187A1 (en) * | 2004-07-26 | 2006-02-01 | AstraZeneca AB | Pharmaceutical multiparticulate tablet formulations and process for their preparation |
US20100015239A1 (en) * | 2008-07-17 | 2010-01-21 | Ahmed Salah U | Orally Disintegrating Solid Pharmaceutical Dosage Forms Comprising Delayed-Release Lansoprazole and Methods of Making and Using the Same |
ES2483744T3 (es) | 2010-04-26 | 2014-08-07 | Dsm Ip Assets B.V. | Nuevo sistema de revestimiento |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
AU2012214553B2 (en) * | 2011-02-11 | 2015-07-09 | Sociétés des Produits Nestlé S.A. | Multiparticulate L-menthol formulations and related methods |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
PL2988824T3 (pl) * | 2013-04-23 | 2019-04-30 | Zx Pharma Llc | Wielocząsteczkowa kompozycja z otoczką dojelitową z białkową otoczką pośrednią |
ITMI20132066A1 (it) * | 2013-12-11 | 2015-06-12 | Farmatron Ltd | Sistemi terapeutici a rilascio modificato per la somministrazione orale di mentolo nel trattamento delle malattie intestinali |
CA2990230A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Compositions and methods for modified nutrient delivery |
WO2016205701A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Enteral fast access tract platform system |
US10736855B2 (en) | 2016-02-25 | 2020-08-11 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
IT202100006893A1 (it) * | 2021-03-22 | 2022-09-22 | Kolinpharma S P A | Una formulazione in forma di microgranuli comprendente un estratto o molecola di origine vegetale avente effetti gastrolesivi o instabilità a ph acido, e una matrice gastroresistente |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755387A (en) * | 1985-03-21 | 1988-07-05 | The Procter & Gamble Company | Therapeutic particles |
LU86099A1 (fr) * | 1985-09-30 | 1987-04-02 | Pharlyse | Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant |
GB8705083D0 (en) * | 1987-03-04 | 1987-04-08 | Euro Celtique Sa | Spheroids |
KR100354702B1 (ko) * | 1993-11-23 | 2002-12-28 | 유로-셀티크 소시에떼 아노뉨 | 약학조성물의제조방법및서방형조성물 |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
US5780055A (en) * | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
UA77145C2 (en) | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
FR2771292B1 (fr) * | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
FR2771291B1 (fr) * | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
FR2774288B1 (fr) * | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
FR2775188B1 (fr) * | 1998-02-23 | 2001-03-09 | Lipha | Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption |
FR2793688B1 (fr) | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
DE19940944B4 (de) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
US6419954B1 (en) * | 2000-05-19 | 2002-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets and methods for modified release of hydrophilic and other active agents |
DE10044299A1 (de) * | 2000-09-07 | 2002-03-21 | Roehm Gmbh | Multipartikuläre Arzneiform und Verfahren zu ihrer Herstellung |
US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
-
2002
- 2002-10-04 FR FR0212333A patent/FR2845289B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-03 SI SI200331253T patent/SI1549298T1/sl unknown
- 2003-10-03 MX MXPA05003588A patent/MXPA05003588A/es active IP Right Grant
- 2003-10-03 AU AU2003283492A patent/AU2003283492A1/en not_active Abandoned
- 2003-10-03 EP EP03775466A patent/EP1549298B1/fr not_active Expired - Lifetime
- 2003-10-03 DE DE60321801T patent/DE60321801D1/de not_active Expired - Lifetime
- 2003-10-03 PT PT03775466T patent/PT1549298E/pt unknown
- 2003-10-03 ES ES03775466T patent/ES2307993T3/es not_active Expired - Lifetime
- 2003-10-03 CA CA2501294A patent/CA2501294C/fr not_active Expired - Fee Related
- 2003-10-03 AT AT03775466T patent/ATE399001T1/de active
- 2003-10-03 WO PCT/FR2003/002909 patent/WO2004030657A1/fr active IP Right Grant
- 2003-10-03 DK DK03775466T patent/DK1549298T3/da active
- 2003-10-03 JP JP2004540887A patent/JP4660192B2/ja not_active Expired - Fee Related
- 2003-10-03 CN CN2003801037982A patent/CN1713896B/zh not_active Expired - Fee Related
- 2003-10-03 US US10/530,052 patent/US20060165794A1/en not_active Abandoned
-
2005
- 2005-12-20 HK HK05111773A patent/HK1077023A1/xx not_active IP Right Cessation
-
2008
- 2008-08-25 CY CY20081100901T patent/CY1108285T1/el unknown
-
2010
- 2010-04-23 US US12/766,176 patent/US9446002B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2004030657A1 (fr) | 2004-04-15 |
SI1549298T1 (sl) | 2008-08-31 |
US20060165794A1 (en) | 2006-07-27 |
EP1549298A1 (fr) | 2005-07-06 |
CA2501294C (fr) | 2013-03-26 |
FR2845289B1 (fr) | 2004-12-03 |
DK1549298T3 (da) | 2008-09-22 |
FR2845289A1 (fr) | 2004-04-09 |
US9446002B2 (en) | 2016-09-20 |
ATE399001T1 (de) | 2008-07-15 |
DE60321801D1 (de) | 2008-08-07 |
ES2307993T3 (es) | 2008-12-01 |
US20100203134A1 (en) | 2010-08-12 |
AU2003283492A1 (en) | 2004-04-23 |
PT1549298E (pt) | 2008-09-16 |
CN1713896A (zh) | 2005-12-28 |
MXPA05003588A (es) | 2005-07-25 |
JP4660192B2 (ja) | 2011-03-30 |
JP2006505540A (ja) | 2006-02-16 |
CA2501294A1 (fr) | 2004-04-15 |
HK1077023A1 (en) | 2006-02-03 |
EP1549298B1 (fr) | 2008-06-25 |
CN1713896B (zh) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108285T1 (el) | Σφαιροειδη, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις | |
ES2167116T3 (es) | Sistema terapeutico transdermico (tts) que contiene pergolida. | |
DE60319355D1 (de) | Kaubare weichkapsel | |
BRPI0409652A (pt) | tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete | |
ES2189868T3 (es) | Microesferas y nanoesferas biodegradables de liberacion controlada que contienen ciclosporina. | |
BRPI0515684A (pt) | formulações de cristais injetáveis ativas de longa duração de metabólitos de estradiol, e métodos de utilização das mesmas | |
BR0309004A (pt) | Matriz para liberação gradual, invariante e independente dos compostos ativos | |
AR012698A1 (es) | Formulacion farmaceutica de omeprazol | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
RS51213B (sr) | Farmaceutski vaginalni gel koji sadrži tenofovir | |
WO2003103637A3 (en) | MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS | |
ATE316779T1 (de) | Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung | |
BRPI0506764A (pt) | microemulsões para composições farmacêuticas | |
PT885014E (pt) | Composicoes farmaceuticas contendo polimeros orto ester tamponados | |
BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
GEP20043285B (en) | Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections | |
DE60022332D1 (de) | Ketoprofen mikrogranulat, verfahren zur herstellung desselben sowie pharmazeutische zusammensetzungen | |
BRPI0510694A (pt) | composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole | |
BRPI0412697A (pt) | composições farmacêuticas que apresentam um revestimento expansìvel | |
MY143793A (en) | Non-tabletted, chewable, individually dosed administration forms | |
TW200504199A (en) | Method of preventing lipids constituting lipid membrane from degradation and use thereof | |
BRPI0707333B8 (pt) | composição farmacêutica que compreende um composto bicíclico, método de estabilização do composto bicíclico e formulação de cápsula de gelatina mole | |
ECSP045232A (es) | Forma de dosificación oral, procedimiento para prepararla y uso de una base débil farmacéuticamente aceptable o una sal o solvato farmacéuticamente aceptable de la misma para preparar dicha forma de dosificación oral | |
ATE392644T1 (de) | Alpha-(1' -hydroxyalkyl)acrylate enthaltende beschichtungsmassen | |
BRPI0412592A (pt) | formulação farmacêutica estável |